Permanent Alopecia in Breast Cancer Patients: Role of Taxanes and Endocrine Therapies

    March 2021 in “ Cutis ”
    Christa Slaught, M del C Souto Roman, Sharona Yashar … Carolyn Goh
    Studysummary This article highlights that permanent chemotherapy-induced alopecia can occur and is more commonly associated with taxane therapy, advising awareness among patients and clinicians.
    Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
    Read the full study on cdn.mdedge.com →
    Discuss this study in the Community →

    Research cited in this study 7

    1. Assessment of Quality of Life and Treatment Outcomes of Patients With Persistent Postchemotherapy Alopecia JAMA Dermatology · 2019
    2. Permanent Alopecia in Patients with Breast Cancer After Taxane Chemotherapy and Adjuvant Hormonal Therapy: Clinicopathologic Findings in a Cohort of 10 Patients Journal of The American Academy of Dermatology · 2017
    3. Permanent Alopecia After Systemic Chemotherapy: A Clinicopathological Study of 10 Cases The American Journal of Dermatopathology · 2011
    4. Permanent Chemotherapy-Induced Alopecia: Case Report and Review of the Literature Journal of The American Academy of Dermatology · 2010
    5. Irreversible And Severe Alopecia Following Docetaxel Or Paclitaxel Cytotoxic Therapy For Breast Cancer British journal of dermatology/British journal of dermatology, Supplement · 2009
    6. Permanent Alopecia After Cranial Irradiation: Dose–Response Relationship International journal of radiation oncology, biology, physics · 2004
    7. The Reliability of Horizontally Sectioned Scalp Biopsies in the Diagnosis of Chronic Diffuse Telogen Hair Loss in Women Journal of The American Academy of Dermatology · 2004